Venus Medtech (Hangzhou) Inc. (HKG:2500)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
1.225
+0.055 (4.70%)
Sep 11, 2026, 4:08 PM HKT

Venus Medtech (Hangzhou) Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
255.15306.79470.83491.37406.46415.86
Revenue Growth
-16.83%-34.84%-4.18%20.89%-2.26%50.65%
Gross Profit
167.37211.83367.75389.21314324.34
Operating Income
-378.77-345.32-365.62-588.55-672.19-281.83
Net Income
-464.23-407.69-714.31-703.75-1,058-373.64
Earnings Per Share
-1.06-0.93-1.63-1.61-2.42-0.85
EPS Growth
------

Revenue by Geography

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Mainland China
146.82208.46388.33418.7354.57405.35
Other countries
108.3398.3282.5172.6751.8910.52
Total
255.15306.79470.83491.37406.46415.86

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
71.29263.77305.7781.641,8792,955
Total Debt
202.69216.34369.09826.19899.6470.78
Net Cash (Debt)
-131.447.43-63.39-44.55979.792,884
Net Cash Growth
-----66.03%7.81%
Net Cash Per Share
-0.300.11-0.14-0.102.246.58

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
--321.3523.74-610.02-729.46-456.92
Capital Expenditures
--10.76-33.92-260.64-169.98-82.07
Free Cash Flow
--332.11-10.18-870.66-899.44-538.99
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
65.60%69.05%78.11%79.21%77.25%77.99%
Operating Margin
-148.45%-112.56%-77.65%-119.78%-165.38%-67.77%
Pretax Margin
-180.67%-131.98%-157.32%-149.65%-284.49%-90.79%
Profit Margin
-181.95%-132.89%-151.71%-143.22%-260.22%-89.85%
FCF Margin
--108.25%-2.16%-177.19%-221.28%-129.61%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
116.4393.6593.6593.6593.6593.65
PS Ratio
1.823.054.914.5513.5925.39